BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10226904)

  • 1. Reversible catecholamine-induced cardiomyopathy in a heart transplant candidate without persistent or paroxysmal hypertension.
    Brilakis ES; Young WF; Wilson JW; Thompson GB; Munger TM
    J Heart Lung Transplant; 1999 Apr; 18(4):376-80. PubMed ID: 10226904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible catecholamine-induced cardiomyopathy due to pheochromocytoma: case report.
    Satendra M; de Jesus C; Bordalo e Sá AL; Rosário L; Rocha J; Bicha Castelo H; Correia MJ; Nunes Diogo A
    Rev Port Cardiol; 2014 Mar; 33(3):177.e1-6. PubMed ID: 24684896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery myointimal dysplasia in patients with pheochromocytoma-possible causal relationship: pathophysiology and clinical implication with reference to Takotsubo cardiomyopathy and spontaneous coronary dissection.
    Chow LTC; Chow MBCY
    Cardiovasc Pathol; 2018; 37():45-53. PubMed ID: 30342321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pheochromocytoma underlying hypertension, stroke, and dilated cardiomyopathy.
    Lin PC; Hsu JT; Chung CM; Chang ST
    Tex Heart Inst J; 2007; 34(2):244-6. PubMed ID: 17622380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac arrest and catecholamine cardiomyopathy secondary to a misdiagnosed ectopic pheochromocytoma.
    Chen X; Liu X; Tian S; Wang X; Tang H; Yu Y; Zhang D; Peng Y
    Endokrynol Pol; 2020; 71(5):479-480. PubMed ID: 32716044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pheochromocytoma presenting after cardiac transplantation for dilated cardiomyopathy.
    Dalby MC; Burke M; Radley-Smith R; Banner NR
    J Heart Lung Transplant; 2001 Jul; 20(7):773-5. PubMed ID: 11448809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of severe cardiac systolic dysfunction caused by pheochromocytoma in a heart transplant candidate.
    Quigg RJ; Om A
    J Heart Lung Transplant; 1994; 13(3):525-32. PubMed ID: 7914746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Catecholamine-induced cardiomyopathy triggered by pheochromocytoma].
    Navarro I; Molina M; Civera M; Ascaso JF; Real JT; Carmena R
    Endocrinol Nutr; 2011 Apr; 58(4):204-6. PubMed ID: 21393076
    [No Abstract]   [Full Text] [Related]  

  • 9. Pheochromocytoma: a cause of ST-segment elevation myocardial infarction, transient left ventricular dysfunction, and takotsubo cardiomyopathy.
    Subramanyam S; Kreisberg RA
    Endocr Pract; 2012; 18(4):e77-80. PubMed ID: 22441003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyopathy due to a pheochromocytoma. A reversible entity.
    Gatzoulis KA; Tolis G; Theopistou A; Gialafos JH; Toutouzas PK
    Acta Cardiol; 1998; 53(4):227-9. PubMed ID: 9842409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart transplantation for end-stage cardiomyopathy caused by an occult pheochromocytoma.
    Wilkenfeld C; Cohen M; Lansman SL; Courtney M; Dische MR; Pertsemlidis D; Krakoff LR
    J Heart Lung Transplant; 1992; 11(2 Pt 1):363-6. PubMed ID: 1576142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of pheochromocytoma complicated with acute renal failure and cardiomyopathy.
    Hamada N; Akamatsu A; Joh T
    Jpn Circ J; 1993 Jan; 57(1):84-90. PubMed ID: 8437346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalization of left ventricular ejection fraction following resection of pheochromocytoma in a patient with dilated cardiomyopathy.
    Hicks RJ; Wood B; Kalff V; Anderson ST; Kelly MJ
    Clin Nucl Med; 1991 Jun; 16(6):413-6. PubMed ID: 1868653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phaeochromocytoma presenting as dilated cardiomyopathy.
    Attar MN; Moulik PK; Salem GD; Rose EL; Khaleeli AA
    Int J Clin Pract; 2003; 57(6):547-8. PubMed ID: 12918898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pheochromocytoma-induced ventricular tachycardia and reversible cardiomyopathy.
    ter Bekke RM; Crijns HJ; Kroon AA; Gorgels AP
    Int J Cardiol; 2011 Feb; 147(1):145-6. PubMed ID: 20022644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute cardiomyopathy and multiorgan failure in a patient with pheochromocytoma and neurofibromatosis type 1.
    Ahmed R; Darrat Y; Hamoudeh E; Elhamdani MO; Yaqub A
    J Pak Med Assoc; 2014 Feb; 64(2):214-6. PubMed ID: 24640818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative management of pheochromocytoma and catecholamine-induced dilated cardiomyopathy in a pediatric patient.
    Kalra Y; Agarwal HS; Smith AH
    Pediatr Cardiol; 2013; 34(8):2013-6. PubMed ID: 23132179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pheochromocytoma-induced acute pulmonary edema and reversible catecholamine cardiomyopathy mimicking acute myocardial infarction.
    Pineda Pompa LR; Barrera-Ramírez CF; Martínez-Valdez J; Rodríguez PD; Guzmán CE
    Rev Port Cardiol; 2004 Apr; 23(4):561-8. PubMed ID: 15224644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible dilated cardiomyopathy after surgical resection of pheochromocytomas associated with von Hippel-Lindau disease.
    Mitsuma W; Ito M; Fujita S; Sato A; Washizuka T; Kodama M; Aizawa Y
    Int J Cardiol; 2009 Jan; 131(3):e95-6. PubMed ID: 17942173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare cause of cardiogenic shock: catecholamine cardiomyopathy of pheochromocytoma.
    Imperadore F; Azzolini M; Piscioli F; Pusiol T; Capitanio A; Vergara G
    Ital Heart J; 2002 Jun; 3(6):375-8. PubMed ID: 12116803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.